Merit Medical Systems (MMSI) Cash from Investing Activities (2010 - 2026)
Merit Medical Systems (MMSI) posted Cash from Investing Activities of -$110.1 million for Q2 2026, down 1524.01% sequentially from $7.7 million in Q1 2026, and up 23.17% YoY from -$89.4 million in Q2 2025.
Merit Medical Systems (MMSI) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Merit Medical Systems has reported Cash from Investing Activities for 17 years, with the latest figure at -$110.1 million in Q2 2026.
- Quarterly Cash from Investing Activities rose 23.17% year-over-year to -$110.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$176.8 million (up 64.86% YoY) and the FY2025 annual result came in at -$247.4 million, up 32.89% from the prior year.
- Cash from Investing Activities slipped to -$110.1 million in Q2 2026 per MMSI's latest filing, from $7.7 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $7.7 million in Q1 2026 and troughed at -$214.4 million in Q4 2024.
- A 5-year average of -$52.8 million and a median of -$19.7 million in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2024 and 2026: Cash from Investing Activities slumped 2470.38% in 2024, then soared 126.1% in 2026.
- Over 5 years, Cash from Investing Activities stood at -$17.3 million in 2022, then surged by 51.86% to -$8.3 million in 2023, then plunged by 2470.38% to -$214.4 million in 2024, then surged by 76.53% to -$50.3 million in 2025, then tumbled by 118.8% to -$110.1 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$110.1 million, $7.7 million, and -$50.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Merit Medical Systems | 5.43 Bn | 4.98 Bn | 215.17 Mn | -110.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -110.13 Mn |
| Jun 30, 2026 | -110.13 Mn |
| Mar 31, 2026 | 7.73 Mn |
| Mar 31, 2026 | 7.73 Mn |
| Dec 31, 2025 | -50.34 Mn |
| Dec 31, 2025 | -50.34 Mn |
| Sep 30, 2025 | -24.07 Mn |
| Sep 30, 2025 | -24.07 Mn |
| Jun 30, 2025 | -143.35 Mn |
| Jun 30, 2025 | -143.35 Mn |
| Mar 31, 2025 | -29.64 Mn |
| Mar 31, 2025 | -29.64 Mn |
| Dec 31, 2024 | -214.45 Mn |
| Dec 31, 2024 | -214.45 Mn |
| Sep 30, 2024 | -115.67 Mn |
| Sep 30, 2024 | -115.67 Mn |
| Jun 30, 2024 | -16.49 Mn |
| Jun 30, 2024 | -16.49 Mn |
| Mar 31, 2024 | -22.05 Mn |
| Mar 31, 2024 | -22.05 Mn |